Lung deposition of inhaled once-daily long-acting muscarinic antagonists via standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients with chronic obstructive pulmonary disease

BACKGROUND: Data for bronchodilator deposition via nebulizers and dry powder inhalers (DPIs) in the respiratory tract of patients with chronic obstructive pulmonary disease (COPD) are limited. We used functional respiratory imaging (FRI) to determine deposition patterns for revefenacin solution via...

Descripción completa

Detalles Bibliográficos
Autores principales: Crater, Glenn D., Johnson, Karmon, Ward, Jonathan, Backer, Jan De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894616/
https://www.ncbi.nlm.nih.gov/pubmed/35234085
http://dx.doi.org/10.1177/17534666221077561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894616/
https://www.ncbi.nlm.nih.gov/pubmed/35234085
http://dx.doi.org/10.1177/17534666221077561

Ejemplares similares